"Receiving FDA clearance for expanded pediatric use marks a significant milestone for iotaMotion and for families navigating cochlear implant decisions," said Mike Lobinsky, CEO of iotaMotion. "By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results